David Medical(300314)

Search documents
戴维医疗(300314.SZ):产品尚未出口至美国
Ge Long Hui· 2025-09-04 07:58
Group 1 - The core viewpoint of the article is that David Medical (300314.SZ) has received FDA certifications for some of its products, although none have been exported to the United States yet [1]
戴维医疗(300314.SZ)产品目前暂未涉及机器人或机器自动化等领域
Ge Long Hui· 2025-09-03 08:14
格隆汇9月3日丨戴维医疗(300314.SZ)在互动平台表示,公司产品目前暂未涉及机器人或机器自动化等 领域。 ...
9月2日晚间重要公告一览
Xi Niu Cai Jing· 2025-09-03 05:04
Group 1 - Huazhong Securities has been approved to issue subordinate corporate bonds with a total face value of no more than 10 billion yuan [1] - Jinbei Automotive plans to invest 240 million yuan to establish an automotive industry investment fund focusing on electrification, intelligence, and low carbon [1] - Linyang Energy is expected to win a bid for a 244 million yuan metering equipment project from Southern Power Grid [1][2] Group 2 - Renfu Pharmaceutical's subsidiary has received drug registration certificates for two products, including a medication for acute hypotension [3][4] - Nanjing Steel plans to distribute a cash dividend of 0.1186 yuan per share [5][6] - Pairui Co. has signed a strategic cooperation agreement with Xi'an Power Electronics Research Institute to develop power devices [7][8] Group 3 - Haixing Electric is expected to win a bid for a 214 million yuan metering equipment project from Southern Power Grid [9][10] - Kuangda Technology is planning a change in control, leading to a continued suspension of its stock [11][12] - Samsung Medical is expected to win a bid for a 274 million yuan metering equipment project from Southern Power Grid [13][14] Group 4 - Jiukang Bio has obtained a medical device registration certificate for a specific diagnostic kit [15][16] - Hechuan Technology's minority shareholder plans to transfer a 13% stake in a subsidiary [17][18] - DiAo Micro has launched a new eUSB2 repeater product for various electronic applications [19][20] Group 5 - David Medical's electric surgical table registration application has been accepted [21][22] - Hangxin Technology plans to apply for a total of 280 million yuan in bank credit [23][24] - Liyuan Technology's non-independent director has resigned [25][26] Group 6 - Ningbo Construction's subsidiary has won a construction project bid worth 729 million yuan [27][28] - Huaren Pharmaceutical's subsidiary has received approval for a raw material drug [29][30] - Suwen Electric plans to distribute a cash dividend of 1 yuan per 10 shares [31][32] Group 7 - Solar Energy has received 1.692 billion yuan in renewable energy subsidies [33][34] - Wangli Security has obtained a patent for a new lock structure [35][36] - Zhejiang Energy's vice chairman has resigned due to age reasons [37][38] Group 8 - Beilu Pharmaceutical's subsidiary has passed GMP certification in Brazil [39][40] - Zhejiang Communications has a subsidiary that is expected to win a highway project bid [41][42] - Xinzhi Group has received a government subsidy of 11.1978 million yuan [43][44] Group 9 - Dong'an Power's engine sales in August increased by 3.44% year-on-year [45][46] - Baiyun Mountain's subsidiary has passed the consistency evaluation for two generic drugs [47][48] - Yipin Hong's subsidiary has received a drug registration certificate for a specific injection [49][50] Group 10 - Far East Holdings' subsidiary has won multiple contracts totaling 1.689 billion yuan [51][52] - Good Housekeeping's shareholder plans to reduce holdings by up to 3.5 million shares [53][54] - Guanghong Technology's shareholders have set a transfer price of 23.33 yuan per share [55][56] Group 11 - Keli Sensor plans to acquire 45% of Huahong Technology's shares for 122 million yuan [57][58] - Jianmin Group's furosemide oral solution has been approved for market launch [59][60] - Jinghua Laser's directors plan to reduce their holdings by up to 143,420 shares [61][62] Group 12 - Zhuyue Group is planning a share transfer that will change its controlling shareholder [63][64] - Terid has pre-bid for two projects totaling approximately 698 million yuan [65][66] - Zhonghuan Hailu is planning a change in control, leading to a continued suspension of its stock and convertible bonds [67][68] Group 13 - Great Wall Motors reported August sales of 115,600 vehicles, a year-on-year increase of 22.33% [69][70] - Guizhou Tire's controlling shareholder has committed not to reduce holdings for 12 months [71][72] - San Da Membrane's shareholder plans to reduce holdings by up to 1% of the company's shares [73][74] Group 14 - Chint Electric has decided to terminate the spin-off of its subsidiary for listing [75][76] - Jusaylong's shareholder plans to reduce holdings by up to 1% of the company's shares [77][78]
戴维医疗:关于公司申报医疗器械注册获得受理的公告
Zheng Quan Ri Bao· 2025-09-02 13:40
Group 1 - The company, David Medical, announced that it has recently obtained a "Notice of Acceptance" issued by the Zhejiang Provincial Drug Administration for its product, an electric surgical table [2] - The acceptance number for the product is: 20254028265 [2] - This development indicates a significant step in the regulatory process for the company's medical equipment [2]
戴维医疗申报医疗器械注册获受理
Zhi Tong Cai Jing· 2025-09-02 08:44
戴维医疗(300314)(300314.SZ)公告,公司近日取得1项由浙江省药品监督管理局颁发的《受理通知 书》,相关产品名称为:电动手术台。 ...
戴维医疗:电动手术台申报医疗器械注册获受理
Zheng Quan Shi Bao Wang· 2025-09-02 08:44
Group 1 - The company, David Medical, announced on September 2 that it has received a "Notice of Acceptance" from the Zhejiang Provincial Drug Administration for its electric surgical table product [1] - The electric surgical table is designed to support high weight capacity in any position, catering to the variability of surgeries and different patient positions [1] - The modular design of the table surface allows it to be suitable for a wide range of surgical procedures [1]
戴维医疗(300314.SZ)申报医疗器械注册获受理
智通财经网· 2025-09-02 08:38
Core Viewpoint - David Medical (300314.SZ) has recently obtained a "Acceptance Notice" issued by the Zhejiang Provincial Drug Administration for its product, an electric surgical table [1] Group 1 - The company has received regulatory approval for its electric surgical table [1]
戴维医疗:公司申报医疗器械电动手术台注册获得受理
Xin Lang Cai Jing· 2025-09-02 08:33
戴维医疗公告称,公司于近日取得1项由浙江省药品监督管理局颁发的《受理通知书》,受理号为:械 受20254028265。本次申报产品为电动手术台,采用电动液压控制方式,通过微型按键开关控制器灵活 控制台面的各种运动,以满足手术所需的各种体位要求。上述医疗器械产品目前所处的审批阶段为注册 申请受理,后续所需的审批流程为技术审评、行政审批、制证。上述品种注册申请受理对公司近期业绩 不会产生影响,后续各阶段所需的时间和结果均具有一定的不确定性。 ...
戴维医疗(300314) - 关于公司申报医疗器械注册获得受理的公告
2025-09-02 08:28
证券代码:300314 证券简称:戴维医疗 公告编号:2025-045 宁波戴维医疗器械股份有限公司 关于公司申报医疗器械注册获得受理的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整, 没有虚假记载、误导性陈述或重大遗漏。 宁波戴维医疗器械股份有限公司(以下简称"公司")于近日取得1 项由浙江省药品监督管理局颁发的《受理通知书》,受理号为:械受 20254028265。具体情况如下: | 序号 | 产品名称 | 注册分类 | 临床用途 | | --- | --- | --- | --- | | | | | 本设备用于常规手术、神经外科、胸腹外 科、骨科、泌尿外科肛肠科、整形外科、 | | 1 | 电动手术台 | Ⅱ类 | 妇科,肝胆外科及普外科手术等医疗过程 | | | | | 的患者多体位支撑与操作,使其躺卧成不 | | | | | 同的姿势。 | 电动手术台是手术治疗中不可缺少的基础医疗设备,主要用于支撑患 者身体、调整手术体位、充分暴露手术野,使医护人员在方便、舒适的条 件下顺利完成各类手术。其核心价值是在于是否安全舒适、好用且耐用。 本次申报产品为电动手术台,采用电动液压控制方式,通过 ...
戴维医疗2025年上半年净利润同比增长9.57%
Zheng Quan Ri Bao Zhi Sheng· 2025-08-23 03:36
今年上半年,戴维医疗坚持实施创新驱动发展战略,持续加大研发投入,优化研发体系,加速产品迭代 升级。公司研发投入达2552.45万元,占营业收入的10.16%。截至六月末,公司及子公司累计拥有专利 257项,其中发明专利70项、实用新型专利138项、外观设计专利49项,计算机软件著作权9项。 (编辑 张伟) 本报讯 (记者吴奕萱)8月22日,宁波戴维医疗器械股份有限公司(以下简称"戴维医疗")发布2025年 半年度报告,公司实现营业收入2.51亿元,较上年同期下降5.48%;实现归属于上市公司股东的净利润 5097.67万元,较上年同期增长9.57%。 公告显示,戴维医疗通过持续深化研发创新、积极拓展市场空间、深入推进精细化管理等关键举措,实 现了经营业绩的稳健发展。 ...